000			03725 a2200421 4500
999			_c10786 _d10786
020			_a9780444642080
050			_aRC347.5 _bSHA 2019
100			_aSharma, Aruna _eeditor
245			_a Nanoneuroprotection and nanoneurotoxicology; volume 245 / _cedited by Aruna Sharma and Hari Shanker Sharma
264			_aCambridge : _bAcademic Press, _c2019
300			_axvii, 303 pages : _billustrations
336			_2rdacontent _atext _btxt
337			_2rdamedia _aunmediated _bn
338			_2rdacarrier _avolume _bnc
440			_aProgress in brain research
500			_avolume 245
504			_aIncludes bibliographical references
505			_aFront Cover; Nanoneuroprotection and Nanoneurotoxicology; Copyright; Contributors; Contents; Preface; References; Acknowledgments; Chapter 1: Sleep deprivation exacerbates concussive head injury induced brain pathology: Neuroprotective effects of nano ... ; 1. Introduction; 1.1. Sleep deprivation and neurological diseases; 1.1.1. Sleep deprivation and cerebrovascular disease; 1.1.2. Alzheimer's disease; 1.1.3. Parkinson's disease; 1.1.4. Epilepsy; 1.1.5. Headache and related disorders; 1.2. Sleep disturbances and traumatic brain injuries 3.2.1. Circulating BDNF in clinical traumatic brain injuries 4. Cerebrolysin and traumatic brain injuries; 4.1. Cerebrolysin and preclinical studies on TBI; 4.2. Cerebrolysin in clinical TBI; 5. Nanodelivery of drugs induce superior neuroprotection; 6. Our own investigations on SD and TBI; 6.1. Methodological consideration; 6.1.1. Methods to induce SD; 6.1.2. Concussive head injury; 6.2. Parameters measured; 6.2.1. Blood-brain barrier permeability; 6.2.2. Brain edema formation and volume swelling; 6.2.3. Brain pathology; 6.3. Biochemical measurements
520			_aNanoneuroprotection and Nanoneurotoxicology, Volume 245 of the Progress in Brain Research series, deals with recent developments in the field of neurotoxicity and neuroprotection using nanobiotechnology for the first time. Chapters in this updated release include Sleep deprivation induced brain pathology and concussive head trauma-Neuroprotective effects of nanowired delivery of drugs and hormones, Nanomedicine in Alzheimer's Disease: amyloid beta targeting strategy, How traumatic brain injury alters amino acids balance in the central nervous system-Neuroprotection by TiO2 nanowired delivery of drugs and antibodies, Nanowired delivery of DL-3-n-butylphthalide and neuroprotection in concussive head injury, Nanodelivery of drugs and antibodies for superior neuroprotection in Alzheimer's disease, and more. Key Features: Highlights recent development in nanopharmacetical research with reference to brain disease; Provides new insights on the possible role of nanomaterials and their pronounced effects on CNS injury or repair. Readership: Researchers and students of neuroscience, psychology, and the biological sciences interested in nanoneuroprotection and nanoneurotoxicology. -- Provided by publisher
650			_a Agents neuroprotecteurs
650			_aDrug Delivery Systems
650			_aHEALTH & FITNESS Diseases General
650			_aMEDICAL Clinical Medicine
650			_aMEDICAL Diseases
650			_aMEDICAL Evidence-Based Medicine
650			_aMEDICAL Internal Medicine
650			_aNervous System Diseases
650			_aNervous system Diseases
650			_aNeuroprotection
650			_aNeuroprotective Agents
650			_aNeuroprotective Agents therapeutic use
650			_aNeuroprotective agents
650			_a Neurotoxicologie
650			_aNeurotoxicology
650			_aNeurotransmitter Agents therapeutic use
700			_aSharma, Hari Shanker _eeditor
942			_2lcc _cBK _h347.5 _iSHA _kRC